Additionally, beyond characterizing a single signaling pathway or intermediate in the induced response, the data present a comprehensive signaling profile in response to curcumin treatment in three cell lines that differ based on the type of rhabdomyosarcoma (ARMS vs. ERMS), p53 status, and associated oncogenic mutations. This evidence concerns the gene TP53 and embryonal rhabdomyosarcoma.